Goldman Sachs

Goldman Sachs Group Inc. Decreases Holdings In Docebo Inc. (nasdaq:dcbo)

Goldman Sachs Group Inc. decreased its position in Docebo Inc. (NASDAQ:DCBO) by 61.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 6,173 shares of the company’s stock after selling 9,793 shares...
Related topics: Nasdaq, US Equity Markets

Read More →

Is Goldman Sachs Equal Weight U.s. Large Cap Equity Etf (gsew) A Strong Etf Right Now?

Designed to provide broad exposure to the Style Box - Large Cap Blend category of the market, the Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) is a smart beta exchange traded fund launched on 09/12/2017.What Are Smart Beta ETFs?The...

Read More →

Best Value Stocks To Buy For December 8th

Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 8th:The Goldman Sachs Group, Inc. GS: This financial institution that provides range of financial services has a Zacks Rank #1 (Strong...

Read More →

Abeona Therapeutics Inc (nasdaq:abeo) Shares Purchased By Goldman Sachs Group Inc.

Goldman Sachs Group Inc. grew its holdings in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) by 145.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned...
Related topics: Nasdaq, US Equity Markets

Read More →

Goldman Sachs (gs) Outpaces Stock Market Gains: What You Should Know

Goldman Sachs (GS) closed at $389.30 in the latest trading session, marking a +1.72% move from the prior day. The stock outpaced the S&P 500's daily gain of 1.17%. At the same time, the Dow added 1.87%, and the tech-heavy Nasdaq gained 0.62%.Heading...
Related topics: Nasdaq, US Equity Markets

Read More →

Goldman Sachs Sees Lower Us Gdp Growth In 2022 On Worries Omicron Could Threaten Recovery

Crowds of people crossing street on zebra crossing in New York, USAAlexander Spatari/Getty Goldman Sachs cut its 2022 US GDP growth outlook on Sunday due to risks posed by the Omicron variant. The bank now sees annual US GDP growth for 2022 at 3.8%,...
Related topics: Banking

Read More →

Macro Briefing: 6 December 2021

* Goldman Sachs cuts forecast of US 2022 GDP growth due to Omicron * US health experts say early signs suggests Omicron less dangerous than delta * China’s economic influence on global economy has been fading * China’s central bank eases...
Related topics: China, Banking

Read More →

Goldman Senior Executives Are Searching For Ways To Quietly Boost Their Own Pay

Goldman Senior Executives Are Searching For Ways To Quietly Boost Their Own Pay What's good for the gander is good for the geese, right? It seems that way at Goldman Sachs. No sooner do we write about how Goldman Sachs is looking to...

Read More →

62,500 Shares In Elevation Oncology, Inc. (nasdaq:elev) Purchased By Goldman Sachs Group Inc.

Goldman Sachs Group Inc. acquired a new stake in shares of Elevation Oncology, Inc. (NASDAQ:ELEV) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 62,500 shares of the...
Related topics: Nasdaq, US Equity Markets

Read More →

Walgreens Lines Up Goldman Sachs To Explore Options For Uk’s Boots Chain

Investment bank will weigh possible sale or spin-off of pharmacy chain
Related topics: United Kingdom, Banking

Read More →

Goldman November Payrolls Preview

A few brief excerpts from a note by Goldman Sachs economist Spencer Hill:We estimate nonfarm payrolls rose 575k in November ... Big Data employment indicators were mixed in the month, and we also see some chance that labor supply constraints weighed...

Read More →

Goldman Sachs Group Inc. Sells 33,608 Shares Of Healthcare Capital Corp. (otcmkts:hcccu)

Goldman Sachs Group Inc. lowered its position in shares of Healthcare Capital Corp. (OTCMKTS:HCCCU) by 20.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor ...

Read More →

Goldman Sachs (gs) Stock Moves -1.44%: What You Should Know

In the latest trading session, Goldman Sachs (GS) closed at $380.99, marking a -1.44% move from the previous day. This change was narrower than the S&P 500's 1.9% loss on the day. Elsewhere, the Dow lost 1.86%, while the tech-heavy Nasdaq added...
Related topics: Nasdaq, US Equity Markets

Read More →

Goldman Sachs Ceo Warns Taxes Could Be Nyc's Downfall, Saying Urban Centers Aren't Guaranteed A...

Goldman Sachs CEO David Solomon warns that New York tax hikes will drive wealthy New Yorkers and corporations out of the state.Associated Press Goldman Sachs' CEO slammed the prospect of tax hikes in NYC, saying they'd threaten its financial...
Related topics: Taxes

Read More →

Here Are Goldman's Four Market-moving Omicron Scenarios

Here Are Goldman's Four Market-Moving Omicron Scenarios Goldman Sachs is out with a comprehensive look at four scenarios for the new Covid-19 'Omicron' strain, which at present appears to be less severe, yet possibly more virulent than...

Read More →

Goldman Sachs Loves These 5 Buy-rated Stocks With Accelerating Sales Growth For 2022

These five top companies have very strong positions in their respective sectors and are expected to post outstanding sales growth in 2022. The value proposition for investors is that their stocks...

Read More →

25 Wall Street Rising Stars At Firms Like Blackstone, Tiger Global, And Goldman Sachs

From left: Julia Jaskolska of CalPERS, Christopher Oglesby of Bank of America, Connie Lee of Tiger Global, and Lalit Gurnani of Goldman Sachs.CalPERS; Bank of America; Tiger Global Management; Goldman Sachs; Samantha Lee/Insider Each year, Insider...
Related topics: Bank Of America, Banking

Read More →

"something Will Rebalance": Goldman Boss Solomon Warns That Market Greed Is Outpacing Fear

"Something Will Rebalance": Goldman Boss Solomon Warns That Market Greed Is Outpacing Fear Goldman Sachs boss David Solomon is the latest to speak out and admit that the market is running at a fever pitch. In kinder terms, Solomon said...

Read More →

Why Bioxcel Therapeutics Is Down Sharply This Week

Shares of BioXcel (NASDAQ: BTAI), a pre-commercial stage biopharmaceutical company, are under pressure this week. A double downgrade from Goldman Sachs analyst Corinne Jenkins from buy to sell has investors thinking twice about a potential new drug...
Related topics: Nasdaq, US Equity Markets

Read More →

Goldman Sachs Projects Inflation To Get Worse Over The Winter

Goldman Sachs expects inflation to get worse over the winter.   Goldman Sachs believes inflation has not yet peaked.  Axios reports: “The current inflation surge will get worse this winter before it gets better,” Goldman Sachs Global...
Related topics: Inflation

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.